03 September 2010
Economists are struggling to explain an exodus of women from Wall Street , but one is not the least bit surprised by the data: Sylvia Ann Hewlett, founding president and chairman of the Center for Work-Life Policy, a nonprofit think tank based in New York. In an article in the Wall Street Journal Ms Hewlett explains why women are leaving Wall Street and this author is wondering if it applies to pharma as well
03 September 2010
It's always good to hear about an older compound that may be doing good things that we didn't realize.
02 September 2010
Tobi Elkin, writer at eMarketer, recently posted about his conversation with Bruce Grant, the SVP at Digitas about where Pharma marketers are and how they can adapt and use the social media space to understand and communicate with their customers. Grant points out that while both online, advertising and social media marketing are two different mechanisms for communicating with the consumers. Social media can, however, provide a platform for consumers to find the answers they need in the cloud of marketing that Pharma presents.
02 September 2010
Help Wanted: CEO for pharmaceutical company who can inspire employees and provide leadership in a time of turmoil. Most be able to focus on patients and have a belief that focusing on customers leads to good business. Fred Hassan of Schering-Plough, by far is a high-paid layoff leader.
01 September 2010
Feedback from clients is the best gift a vendor can get.
03 September 2010
Because of the long holiday weekend looming here in the U.S., I anticipate that today will be pretty slow. Therefore, it's a good time to record something personal and not offend my readers who may be looking for a "Mack Attack" such as the one I launched yesterday against Allergan, which I labeled an "unethical marketer and the the drug industry poster boy for off-label promotion" ( see here ). I guess most people started their vacations yesterday, because I didn't get any response to that attack
03 September 2010
The sun sets on a summer.
02 September 2010
Blogging time is short today, since I'm on a deadline to produce a couple of posters for presentation. These are for an internal hoe-down, unfortunately, so I won't be able to share the fruits of my labors with everyone out there in the readership. With any luck, though, they'll turn into public presentations/publications eventually, though
02 September 2010
Allergan -- the company that markets Botox legally for wrinkles and illegally for other things -- agreed to pay $600 million in fines, including $375 million to the government as part of a Botox “misbranding” charge. Allergan admitted that its marketing of Botox from 2000 to 2005 led to intended use in treating headache, pain, muscle stiffness and juvenile cerebral palsy. Read the media stories and press releases here
01 September 2010
Soon after I posted a blog entry and tweeted about cholesterol-lowering drugs (see here ), I "coincidentally" received the following e-mail message (click for an enlarged, readable view): I do not remember opting in to receive email from Insyst Media -- the company that sent me this email. But, who knows, it may be one of those "third-party partners" of a website where I signed up to learn more about cholesterol
